HomeYMAB • NASDAQ
add
Y-mAbs Therapeutics Inc
Previous close
$17.25
Day range
$16.99 - $17.78
Year range
$4.60 - $20.90
Market cap
750.78M USD
Avg Volume
329.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 23.36M | -25.71% |
Operating expense | 24.52M | -18.16% |
Net income | -988.00K | -185.39% |
Net profit margin | -4.23 | -214.95% |
Earnings per share | -0.02 | -166.67% |
EBITDA | -3.04M | -892.81% |
Effective tax rate | -24.59% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 78.64M | -25.65% |
Total assets | 127.87M | -9.61% |
Total liabilities | 26.88M | -16.60% |
Total equity | 100.98M | — |
Shares outstanding | 43.78M | — |
Price to book | 7.47 | — |
Return on assets | -6.23% | — |
Return on capital | -7.83% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -988.00K | -185.39% |
Cash from operations | -8.04M | 7.22% |
Cash from investing | — | — |
Cash from financing | 100.00K | — |
Net change in cash | -7.93M | 9.47% |
Free cash flow | -11.05M | -86.35% |
About
Founded
2015
Website
Employees
100